UroGen Pharma (URGN) Shares Outstanding (Weighted Average) (2016 - 2025)
Historic Shares Outstanding (Weighted Average) for UroGen Pharma (URGN) over the last 10 years, with Q3 2025 value amounting to $48.1 million.
- UroGen Pharma's Shares Outstanding (Weighted Average) rose 273.14% to $48.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.1 million, marking a year-over-year increase of 273.14%. This contributed to the annual value of $47.0 million for FY2024, which is 3008.6% up from last year.
- As of Q3 2025, UroGen Pharma's Shares Outstanding (Weighted Average) stood at $48.1 million, which was up 273.14% from $47.7 million recorded in Q2 2025.
- UroGen Pharma's Shares Outstanding (Weighted Average)'s 5-year high stood at $48.1 million during Q3 2025, with a 5-year trough of $22.2 million in Q1 2021.
- Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $23.5 million (2023), whereas its average is $32.1 million.
- In the last 5 years, UroGen Pharma's Shares Outstanding (Weighted Average) surged by 146.09% in 2021 and then skyrocketed by 7262.5% in 2024.
- Quarter analysis of 5 years shows UroGen Pharma's Shares Outstanding (Weighted Average) stood at $22.3 million in 2021, then rose by 2.06% to $22.8 million in 2022, then surged by 58.52% to $36.2 million in 2023, then surged by 30.09% to $47.0 million in 2024, then grew by 2.18% to $48.1 million in 2025.
- Its Shares Outstanding (Weighted Average) was $48.1 million in Q3 2025, compared to $47.7 million in Q2 2025 and $47.4 million in Q1 2025.